This inventor holds 1 USPTO granted patent. Top assignee: Institute of Basic Medical Sciences, Cams. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yanjiang Xing: Innovator in Pulmonary Hypertension Treatment
Introduction
Yanjiang Xing is a prominent inventor based in Beijing, China. He has made significant contributions to the field of medical science, particularly in the treatment of pulmonary hypertension. His innovative approach has led to the development of a unique drug formulation that holds promise for patients suffering from this condition.
Latest Patents
Yanjiang Xing holds a patent for the "Use of Malic Enzyme 1 (ME1) in Preparation of Drug for Preventing and Treating Pulmonary Hypertension (PH)." This patent represents a breakthrough in the therapeutic strategies available for managing pulmonary hypertension, showcasing his commitment to advancing medical treatments.
Career Highlights
Xing is affiliated with the Institute of Basic Medical Sciences, CAMS, where he conducts research and develops innovative solutions for complex medical challenges. His work has been recognized for its potential impact on patient care and treatment outcomes.
Collaborations
Throughout his career, Yanjiang Xing has collaborated with esteemed colleagues, including Xianmei Qi and Jing Wang. These partnerships have fostered a collaborative environment that enhances research and innovation in the medical field.
Conclusion
Yanjiang Xing's contributions to the treatment of pulmonary hypertension through his patented work exemplify the vital role of inventors in advancing healthcare. His dedication to research and innovation continues to inspire progress in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile